SCNI
Scinai Immunotherapeutics
SCNI
SCNI
17 hedge funds and large institutions have $560K invested in Scinai Immunotherapeutics in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
37% less capital invested
Capital invested by funds: $891K → $560K (-$331K)
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$57.2K | |
| 2 | +$46.5K | |
| 3 | +$30.8K | |
| 4 |
HF
HRT Financial
New York
|
+$8.47K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.82K |
Top Sellers
| 1 | -$259K | |
| 2 | -$33K | |
| 3 | -$15.7K | |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$14K |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.8K |